文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

优化男男性行为者沙眼衣原体与淋病奈瑟菌筛查策略的模型研究

Optimizing Strategies for Chlamydia trachomatis and Neisseria gonorrhoeae Screening in Men Who Have Sex With Men: A Modeling Study.
PubMed 文献 · Clin Infect Dis · 2020-01-01

该模型研究基于1255例MSM的2973份三联位点样本,评估五种NG/CT筛查策略。与每3个月三联位点筛查相比,每3个月肛门咽部采样仅漏诊6.3%/10.5%的NG/CT诊断,且成本降低33%。

要点

  • 每3个月肛门咽部采样是漏诊率与成本平衡的最佳策略。
  • 每12个月三联位点筛查漏诊NG/CT达42.0%/41.2%,成本降低74%。
  • 基础场景NG/CT患病率12.0%/11.1%,发病率40/29每百人年。

核心结论

  • 每3个月肛门咽部采样(S5)似乎是最佳策略,仅漏诊6.3%/10.5%的NG/CT诊断,成本降低33%。

研究设计与样本

  • 采用NG/CT筛查与感染的区室模型,基于MSM性病门诊的肛门、咽部、尿液三联位点样本估计筛查率、患病率和发病率。

主要发现

  • 分析1255例患者的2973份三联位点样本,观察到485例NG和379例CT诊断。
  • 基础场景NG/CT患病率为12.0%/11.1%,发病率为40/29每百人年。
  • 与S2(每3个月三联位点)相比,S1漏诊42.0%/41.2%,S3漏诊21.8%/22.5%,S4漏诊25.6%/28.3%,S5漏诊6.3%/10.5%。
  • 与S2相比,S1降低成本74%,S3降低50%,S4降低66%,S5降低33%。
  • 为弥补漏诊所需筛查人数:S1为49/67,S3为62/82,S4为71/87,S5为143/118。

关键数值与推荐

  • S1:每12个月三联位点采样;S2:每3个月三联位点采样;S3:每6个月三联位点采样;S4:每6个月肛门咽部采样;S5:每3个月肛门咽部采样。

临床怎么用

  • 在MSM人群NG/CT筛查中,可考虑每3个月肛门咽部采样以兼顾漏诊率与成本。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: International guidelines recommend the systematic screening for Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) infections in all men who have sex with men (MSM) who have engaged in unprotected sex. However, the optimal screening strategy remains unclear. We developed a modeling approach to optimize NG/CT screening strategy in MSM. METHODS: A compartmental model of NG/CT screening and infection was implemented. NG/CT anal, pharyngeal, and urine (APU) samples from MSM attending the sexually transmitted infections clinic were used to estimate the screening rate, prevalence, and incidence in a base case scenario. Different screening strategies (scenarios; S) were then evaluated: APU samples every 12 months (S1); APU samples every 3 months (S2); APU samples every 6 months (S3); anal and pharyngeal (AP) samples every 6 months (S4); and AP samples every 3 months (S5). RESULTS: We analyzed 2973 triplet APU samples from 1255 patients. We observed 485 NG and 379 CT diagnoses. NG/CT prevalence and incidence estimates were 12.0/11.1% and 40/29 per 100 person-years, respectively, in the base case scenario. As compared to S2, the reference strategy, the proportions of missed NG/CT diagnoses were 42.0/41.2% with S1, 21.8/22.5% with S3, 25.6/28.3% with S4, and 6.3/10.5% with S5, respectively. As compared to S2, S1 reduced the cost of the analysis by 74%, S3 by 50%, S4 by 66%, and S5 by 33%. The numbers needed to screen for catching up the missed NG/CT diagnoses were 49/67 with S1, 62/82 with S3, 71/87 with S4, and 143/118 with S5. CONCLUSIONS: S5 appears to be the best strategy, missing only 6.3/10.5% of NG/CT diagnoses, for a cost reduction of 33%.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Voirin N, Allam C, Charre C, et al. Optimizing Strategies for Chlamydia trachomatis and Neisseria gonorrhoeae Screening in Men Who Have Sex With Men: A Modeling Study. Clin Infect Dis. 2020. PMID: 31198933. doi:10.1093/cid/ciz510

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。